{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:36Z","timestamp":1786119576191,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/qai.0b013e3181f9fb39","type":"journal-article","created":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T06:29:58Z","timestamp":1286346598000},"page":"349-355","source":"Crossref","is-referenced-by-count":78,"title":["Tuberculosis in Patients Receiving Antiretroviral Treatment: Incidence, Risk Factors, and Prevention Strategies"],"prefix":"10.1097","volume":"56","author":[{"given":"Annelies","family":"Van Rie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Westreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Sanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20210131","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R3-10-20210131","first-page":"1026","article-title":"HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult\/Adolescent Spectrum of HIV Disease Group.","volume":"4","author":"Jones","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"R4-10-20210131","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1164\/ajrccm.162.3.9908018","article-title":"Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.","volume":"162","author":"Kirk","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-10-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"},{"key":"R6-10-20210131","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R7-10-20210131","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection.","volume":"14","author":"Girardi","year":"2000","journal-title":"AIDS"},{"key":"R8-10-20210131","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1371\/journal.pone.0000826","article-title":"Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.","volume":"2","author":"Miranda","year":"2007","journal-title":"PLoS One"},{"key":"R9-10-20210131","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R10-10-20210131","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R11-10-20210131","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/01.aids.0000232235.26630.ee","article-title":"Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.","volume":"20","author":"Bonnet","year":"2006","journal-title":"AIDS"},{"key":"R12-10-20210131","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1086\/522986","article-title":"Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.","volume":"45","author":"Brinkhof","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R13-10-20210131","first-page":"318","article-title":"Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.","volume":"14","author":"Dembele","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R14-10-20210131","first-page":"69","article-title":"Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.","volume":"56","author":"Rajasekaran","year":"2009","journal-title":"Indian J Tuberc"},{"key":"R15-10-20210131","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","article-title":"Immune reconstitution and unmasking of tuberculosis during antiretroviral therapy.","volume":"177","author":"Lawn","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-10-20210131","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"R17-10-20210131","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1758-2652-12-38","article-title":"Long term outcomes of antiretroviral therapy in a large HIV\/AIDS care clinic in urban South Africa: a prospective cohort study.","volume":"12","author":"Sanne","year":"2009","journal-title":"J Int AIDS Soc"},{"key":"R18-10-20210131","first-page":"117","article-title":"The relation ship between the risk of tuberculosis infection and the risk of developing infectious tuberculosis.","volume":"60","author":"Styblo","year":"1985","journal-title":"Bull Int Union Tuberc Lung Dis"},{"key":"R19-10-20210131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/ije\/dyp308","article-title":"A consistent log-linear relationship between tuberculosis incidence and body mass index.","volume":"39","author":"Lonnroth","year":"2010","journal-title":"Int J Epidemiol"},{"key":"R20-10-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.","volume":"172","author":"Seyler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-10-20210131","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1097\/QAD.0b013e32832e05c8","article-title":"Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"R23-10-20210131","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/429825","article-title":"High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.","volume":"40","author":"Mtei","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R24-10-20210131","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1371\/journal.pmed.0040022","article-title":"Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease.","volume":"4","author":"Corbett","year":"2007","journal-title":"PLoS Med"},{"key":"R25-10-20210131","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1164\/rccm.200606-759OC","article-title":"Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control.","volume":"175","author":"Wood","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-10-20210131","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.","volume":"23","author":"Golub","year":"2009","journal-title":"AIDS"},{"key":"R27-10-20210131","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201104010-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:38:26Z","timestamp":1786041506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201104010-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181f9fb39","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}